UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1453-1463

2018

Volltextzugriff (PDF)

Anthracycline-induced cardiotoxicity

Annals of internal medicine, 1996-07, Vol.125 (1), p.47

1996

Volltextzugriff (PDF)

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Journal of the American College of Cardiology, 2000-03, Vol.35 (4), p.922-928

2000

Volltextzugriff (PDF)

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

British heart journal, 2003-10, Vol.89 (10), p.1200-1204

2003

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Journal of the American College of Cardiology, 2000-04, Vol.35 (5), p.1103-1115

2000

Volltextzugriff (PDF)

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

Circulation (New York, N.Y.), 1996-10, Vol.94 (7), p.1690-1697

1996

Volltextzugriff (PDF)

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Heart (British Cardiac Society), 2006-07, Vol.92 (7), p.945-950

2006

Volltextzugriff (PDF)

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach

European heart journal, 2007-08, Vol.28 (16), p.1936-1945

2007

Volltextzugriff (PDF)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Circulation (New York, N.Y.), 1998-12, Vol.98 (25), p.2829-2835

1998

Volltextzugriff (PDF)

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

European heart journal, 2004-02, Vol.25 (4), p.313-321

2004

Volltextzugriff (PDF)

Rapid platelet-function assay: An automated and quantitative cartridge-based method

Circulation (New York, N.Y.), 1999-02, Vol.99 (5), p.620-625

1999

Volltextzugriff (PDF)

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

Journal of the American College of Cardiology, 1997-03, Vol.29 (4), p.808-816

1997

Volltextzugriff (PDF)

Cell adhesion molecules in coronary artery disease

Journal of the American College of Cardiology, 1994-12, Vol.24 (7), p.1591-1601

1994

Volltextzugriff (PDF)

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

Circulation (New York, N.Y.), 1993-09, Vol.88 (3), p.1361-1374

1993

Volltextzugriff (PDF)

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Diabetes care, 2018-08, Vol.41 (8), p.1792-1800

2018

Volltextzugriff (PDF)

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

European heart journal, 2000-03, Vol.21 (5), p.371-381

2000

Volltextzugriff (PDF)

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial

Journal of thrombosis and haemostasis, 2005-03, Vol.3 (3), p.439-447

2005

Volltextzugriff (PDF)

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

Circulation (New York, N.Y.), 2000-02, Vol.101 (4), p.366-371

2000

Volltextzugriff (PDF)

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

Circulation (New York, N.Y.), 1999-11, Vol.100 (19), p.1977-1982

1999

Volltextzugriff (PDF)

Local intraluminal infusion of biodegradable polymeric nanoparticles : A novel approach for prolonged drug delivery after balloon angioplasty

Circulation (New York, N.Y.), 1996-09, Vol.94 (6), p.1441-1448

1996

Volltextzugriff (PDF)

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome

The journal of clinical endocrinology and metabolism, 2018-07, Vol.103 (7), p.2522-2533

2018

Volltextzugriff (PDF)

Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization

Journal of the American College of Cardiology, 1997-07, Vol.30 (1), p.149-156

1997

Volltextzugriff (PDF)

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

The American heart journal, 2000-07, Vol.140 (1), p.74-80

2000

Volltextzugriff (PDF)

Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model

Circulation (New York, N.Y.), 1995-11, Vol.92 (10), p.3041-3050

1995

Volltextzugriff (PDF)

1 – 25 von 590

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(523)
Mit Volltextzugriff
(491)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(588)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(351)
Life Sciences & Biomedicine
(348)
Humans
(322)
Cardiovascular System & Cardiology
(232)
Cardiac & Cardiovascular Systems
(222)
Biological And Medical Sciences
(217)
Male
(215)
Medical Sciences
(214)
Female
(200)
Middle Aged
(199)
Aged
(158)
Treatment Outcome
(107)
Pharmacology. Drug Treatments
(91)
Platelet Aggregation Inhibitors - Therapeutic Use
(90)
Platelet Glycoprotein Gpiib-Iiia Complex - Antagonists & Inhibitors
(84)
Angioplasty, Balloon, Coronary
(76)
Cardiology. Vascular System
(73)
Risk Factors
(73)
Heart Attacks
(67)
Blood. Blood Coagulation. Reticuloendothelial System
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial

Anthracycline-induced cardiotoxicity

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

Rapid platelet-function assay: An automated and quantitative cartridge-based method

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

Cell adhesion molecules in coronary artery disease

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

Local intraluminal infusion of biodegradable polymeric nanoparticles : A novel approach for prolonged drug delivery after balloon angioplasty

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome

Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model

Suchergebnisse filtern